Comparisons of beta-adrenergic blocking properties of S- and R-timolol in humans.

Article Details

Citation

Copy to clipboard

Rotmensch HH, Vlasses PH, Feinberg JA, Abrams WB, Ferguson RK

Comparisons of beta-adrenergic blocking properties of S- and R-timolol in humans.

J Clin Pharmacol. 1993 Jun;33(6):544-8.

PubMed ID

8103526 [ View in PubMed

]

Abstract

In animals, the R-enantiomer of timolol causes a significant reduction in intraocular pressure but had only 1/80 the activity of the S-enantiomer at extraocular receptors. The beta 1- and beta 2-adrenoceptor blocking properties of orally administered R- and S-timolol were compared in a double-blind placebo controlled trial in two groups of healthy men. Each subject in group A (n = 6) received placebo, 1 and 3 mg S-timolol and 25 and 75 mg R-timolol in random order, group B (n = 5) received placebo, 0.5, and 1 mg S-timolol and 3 and 10 mg R-timolol. In both groups, R- and S-timolol comparably inhibited isoproterenol-induced increases in heart rate (P < .05), forearm blood flow (P < .05, except at 3 micrograms/minute of isoproterenol after the R-doses in group B), and finger tremor (P < .05) in comparison with placebo. The findings for the R-enantiomer in this study were unexpected based on the animal studies and previous studies that demonstrated marked differences in beta blocking effects of other beta-blockers in which the R-enantiomers were less inhibitory.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Timolol	Beta-2 adrenergic receptor	Protein	Humans	Yes	Antagonist	Details